Company Search:
Advanced Search
Sponsored Links
NovAccess Global Inc Company Snapshot
NovAccess Global, Inc., formerly XsunX, Inc., is a biomedical company. The Company focuses to provide diagnostics and therapeutics for cancer and neurological diseases. The Company utilizes immunotherapy approaches to enhance the patient's own immune cells to recognize and kill cancer cells. It is engaged in developing technology that utilizes artificial intelligence platforms to provide personalized and patient-centered care. Its technology, StemVax Therapeutics, has an immunotherapeutic approach to treat brain tumor patients with glioblastoma multiforme. The Company's technology is designed to combine a dendritic cell-based immunotherapeutic approach with a combination of Toll-like receptor (TLR) adjuvants, TLR-AD1, to help promote immune response against the patient's tumor. Its combination of TLR adjuvants, in addition to the tumor's antigens, obtained from the patient, promotes immune response.

Sales Analysis. NovAccess Global Inc reported sales of $1.61 million for the fiscal year ending September of 2019. This represents an increase of 141.9% versus 2018, when the company's sales were $665,017.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
NovAccess Global Inc
  Stock Performance Chart for NovAccess Global Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): .52
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks 3.0%  
4 Weeks 71.7%   52 Weeks -14.2%  
NovAccess Global Inc Key Data:
  Ticker: XSNX Country: United States
  Exchanges: OTC Major Industry: Materials
    Sub Industry: Unsupported Plastics Film & Sheet
  2019 Sales 1,608,723
(Year Ending Jan 2020).
Employees: 3
  Currency: U.S. Dollars Market Cap: 824,972
  Fiscal Yr Ends: September Shares Outstanding: 1,601,888
  Share Type: Common Closely Held Shares: 1,601,887
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.